CAVAZZA CLAUDIO has a total of 128 patent applications. Its first patent ever was published in 1972. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Belgium. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are EVOKE PHARMA INC, ACERUS BIOPHARMA INC and EDGE THERAPEUTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 26 | |
#2 | WIPO (World Intellectual Property Organization) | 13 | |
#3 | Belgium | 7 | |
#4 | Canada | 7 | |
#5 | Switzerland | 7 | |
#6 | France | 7 | |
#7 | United Kingdom | 7 | |
#8 | Japan | 7 | |
#9 | Netherlands | 7 | |
#10 | Germany | 6 | |
#11 | Denmark | 5 | |
#12 | Ireland | 5 | |
#13 | Israel | 5 | |
#14 | Luxembourg | 5 | |
#15 | Australia | 4 | |
#16 | Norway | 2 | |
#17 | Austria | 1 | |
#18 | Brazil | 1 | |
#19 | Spain | 1 | |
#20 | Greece | 1 | |
#21 | Italy | 1 | |
#22 | Republic of Korea | 1 | |
#23 | Mexico | 1 | |
#24 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Machines | |
#6 | Packaging and shipping | |
#7 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Cavazza Claudio | 60 |
#2 | Diamanti Enrico | 8 |
#3 | Kuraujio Kabaza | 6 |
#4 | Witt Paolo De | 6 |
#5 | Pisano Claudio | 4 |
#6 | Cavazza C | 4 |
#7 | Carminati Paolo | 3 |
#8 | Calvani Menotti | 3 |
#9 | Carminati Silvia | 2 |
#10 | Singrossi Gabriella | 2 |
Publication | Filing date | Title |
---|---|---|
WO0164204A2 | Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents | |
WO0000183A2 | Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin | |
US4330557A | Acyl-carnitine and use thereof in parenteral administration of triglycerides | |
US4346107A | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism | |
KR820001460B1 | Process for manufacturing d-camphorate of l-carnitinamide and d-carnitinamide | |
ATA473779A | Method for producing the d-camphorate of l-carnitinamide | |
IL57372D0 | Pharmaceutical composition for total parenteral nutrition comprising carnitine derivatives | |
CH642549A5 | Polysalinic solution for hemodialysis, containing carnitine. | |
US4195731A | Device for containing a substance to be mixed with another substance in a vial | |
US4021436A | Derivatives of nicotinic acid with amines variously substituted | |
AU3775572A | A dual compartment mixing container | |
CA872769A | Preparation of a gelatinous compound |